Opioid trial

CLEVELAND (AP) — Lawyers in the first federal opioid trial resumed selecting a jury Thursday even as a push continued to settle the case before arguments begin.

The second day of picking a jury began after U.S. District Judge Dan Polster, for the second day in a row, denied a request from defendants to delay the trial because of reports of a settlement offer.

By late Thursday morning, 24 potential jurors had been qualified, so the sides could start removing jurors from the pool without giving a reason. One complication in selecting a jury is that the pool comes from counties around Cleveland that have been hard hit by the crisis.

Federal data shows that from 2006 through 2012, the area received more doses of opioids per person than the national median.

Arguments are scheduled to begin Monday against some of the biggest names in the pharmaceutical industry unless they can strike a deal.

A source familiar with the negotiations described the outlines of a tentative nationwide settlement as worth tens of billions of dollars. The talks involve the distributors AmerisourceBergen, Cardinal Health and McKesson, as well as drug makers Johnson & Johnson and Teva.

Another $14 billion would come from distribution of those drugs, based on calculations of how much a distributor could charge for them.

The person spoke to The Associated Press on the condition of anonymity because the talks were continuing. Samantha Fisher, a spokeswoman for the Tennessee attorney general’s office, confirmed a $50 billion settlement framework that was first reported by The New York Times.

If a tentative settlement is reached in the days ahead, it would need sign-off by the states and local governments that have sued numerous players in the opioid industry. Perhaps the most well-known of those, OxyContin maker Purdue Pharma, was taken out of the consolidated federal lawsuits after it filed last month for bankruptcy protection.

The litigation is being overseen by a U.S. District Court judge in Cleveland, who is moving ahead with an initial trial that involves Ohio’s Cuyahoga and Summit counties. They claim the companies engaged in a conspiracy that has ravaged their communities, while the companies say they complied with the law and supplied only drugs that doctors prescribed.

Several companies, including Johnson & Johnson, have already reached settlements with the two counties and have been removed from the trial. If the three distributors and two manufacturers succeed in getting a nationwide settlement, it would leave only two defendants in the immediate case: the pharmacy chain Walgreens, in its role as a distributor to its own stores; and Henry Schein, a small distributor.

While the case concerns only claims for the two counties, it can pave the way for resolving more than 2,000 other lawsuits filed over the opioid crisis.